Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 156
Selected: 0
NCT IDTitle
NCT064924602 Courses of Concurrent Cisplatin Chemoradiotherapy After Surgery for High-risk Head and Neck Squamous Cell Carcinoma
NCT06321939Sequencing-based Counting of Plasma Epstein-Barr Virus DNA in Non-metastatic Nasopharyngeal Carcinoma
NCT04103853Safety, Tolerability, and Pharmacokinetics of Proxalutamide Therapy in Women With Metastatic Breast Cancer
NCT01616849Study of Chemotherapy Combined With Nimotuzumab in Untreated Metastatic Nasopharyngeal Carcinoma
NCT06327698Cadonilimab in Combination With Anlotinib in the Treatment of Locally Progressive or Metastatic Melanoma With First-Line Therapy Failure
NCT06995118The Application of "HUAXI Hole 1" in Reverse-sequence Endoscopic Nipple-sparing Mastectomy With Direct-to-implant Breast Reconstruction
NCT04974827A Study of Camrelizumab Combined With Concurrent Chemoradiation in Patients With Cervical Cancer
NCT02876861Neoadjuvant Chemotherapy Versus Surgery Alone in Patients With High-Grade UTUC
NCT06591078Evaluation of Clinical Efficacy of Acupuncture in Improving Immune Response in Patients With Cervical Cancer
NCT05512286Patient-Reported Outcome and Safety Between Preoperative and Postmastectomy Radiotherapy in DIEP Flap Reconstruction
NCT07163481A Trial to Evaluate Sacituzumab Govitecan in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Metastatic Breast Cancer Progressed on CDK4/6 Inhibitors
NCT05342792Metronomic Capecitabine With or Without PD-1 Antibody as Adjuvant Therapy in High-risk Nasopharyngeal Carcinoma
NCT05356351An Open-label, Single-arm, Multicenter Phase II Clinical Study: Evaluating RC48-ADC Combined With Triplizumab in the Neoadjuvant Treatment of Her2-positive Muscle-invasive Bladder Cancer
NCT02527057Diffusion-weighted Magnetic Resonance Imaging (DW-MRI )for Early Response Assessment in Patients With Esophageal Cancer
NCT06788002LDRT and Chemoimmunotherapy in NPC With Liver Metastasis
NCT03880695Anlotinib Hydrochloride Combined With Liposomal Doxorubicin in the Treatment of Locally Advanced or Metastatic Soft Tissue Sarcoma
NCT03236649The Phase III Study of Icaritin Versus Sorafenib in PD-L1 Positive Advanced Hepatocellular Carcinoma Subjects
NCT03146455Thromboelastography Normal Reference Values in China Hunan Province
NCT06033287Real-World Study on CDK4/6 Inhibitors Combined With Endocrine Therapy and Subsequent Treatment in HR+/HER2- MBC.
NCT06031376Fruquintinib With PD-1 Inhibitors Versus TAS-102 With Bevacizumab in Late-Line mCRC
NCT05113017The Effectiveness and Safety of SBRT in the Treatment of Patients With MPLC After Surgery (SMILE)
NCT02891083Adjuvant Therapies or Surgery Alone for High Risk pN0 Esophageal Cancer
NCT05430399Utidelone Versus Docetaxel in HER2-negative Locally Advanced or Metastatic Breast Cancer
NCT06836869Modified Tumor-free Techniques Operation to Cervical Cancer
NCT04136886Concurrent Chemotherapy for Recurrent T3/T4 Nasopharyngeal Carcinoma
NCT03503136Nedaplatin Versus Cisplatin and Capecitabine Versus Fluorouracil in IC + CCRT for Locoregionally Advanced NPC
NCT07314216Firmonertinib Combined With Definitive Radiotherapy in Stage III Unresectable EGFR Uncommon Mutant Pulmonary Adenocarcinoma
NCT05268172IFN-γ Combined With T Cells in the Treatment of Refractory Malignant Pleural Effusion and Ascites
NCT05430906AK104 Combined With Chemotherapy as Neoadjuvant Treatment for Advanced Ovarian Cancer
NCT0655759018F-FAPI-04 PET/CT and PET/MR in Patients With Various Types of Malignant Tumors
NCT03286920Effect of Postoperative Family Nutrition Mode on Weight/BMI of Patients With Esophageal Cancer
NCT02355249Traditional Three Incisions vs Minimally Invasive Thoracol-laparoscopic Esophagectomy for Esophageal Cancer
NCT06440954Efficacy and Resistance Mechanisms of IP in NSCLC With Leptomeningeal Metastases
NCT07654634Precision Antithrombotic Therapy
NCT06190652Real-world Experience of ICIs Plus Chemotherapy With or Without Radiotherapy for Advanced ESCC.
NCT06840704Immunonutrition Reduces Acute Esophagitis After Thoracic Radiotherapy in Lung Cancer
NCT04140552Chinese Research Group of Gallbladder Cancer
NCT04193319Effect of Fluconazole on PK of Fluzoparib in Healthy Male Subjects
NCT07176962A Cell-free DNA Methylation Blood-Based Test for Biliary Tract Cancers Screening
NCT07303283Becotatug Vedotin as Adjuvant Therapy For High-risk Nasopharyngeal Carcinoma
NCT05206656Safety and Efficacy of Eribullin or Eribulin Combined With Anlotinib in Metastatic Breast Cancer
NCT05107011Phase I/II Clinical Trial of LBL-015 for Injection
NCT01470495Combined Treatment of RFA and Sorafenib on Recurrent HCC
NCT04767295A Study of Camrelizumab Combined With Chemotherapy as Neoadjuvant Therapy in Adcanced Esophageal Squamous Cell Carcinoma (ESCC)
NCT07674368Rucaparib Monoclonal Antibody for Lorlatinib-Induced Hypercholesterolemia / Mixed
NCT04459078Clinical Study of Camrelizumab Combined With APatinib and Albumin Paclitacxel in Patients With Advanced Lung Adenocarcinoma
NCT05955391TGRX-326 Chinese Phase II for Advanced Non-small Cell Lung Cancer (NSCLC)
NCT04733820Clinical Efficacy of Adjuvant Chemotherapy in Patients With Locally Advanced Cervical Cancer Who Did Not Meet the NCCN Guidelines for Adjuvant Treatment After NACT Combined With Surgery
NCT03994744Assessing Safety and Efficacy of Sintilimab and Metformin Combination Therapy in SCLC
NCT07402525Postoperative Radiotherapy for Early-stage Oral Tongue Squamous Cell Carcinoma Patients With Risk Factors: a Prospective, Multicenter, Randomized Controlled, Open-labelled Trial